Literature DB >> 8013494

In vitro activity of ceftriaxone combined with tazobactam against anaerobic bacteria.

J Wüst1, U Hardegger.   

Abstract

The in vitro activity of ceftriaxone combined with tazobactam against 190 strains of anaerobic bacteria was compared with that of amoxicillin with clavulanic acid, ampicillin with sulbactam, piperacillin alone and with tazobactam, cefoxitin, and imipenem, i.e. beta-lactam antibiotics established in the treatment of anaerobic infections. All anaerobes tested were susceptible to < or = mg/l ceftriaxone when tazobactam was added at fixed ratios (ceftriaxone to tazobactam) of 2:1 and 8:1 and at constant concentrations of 2,4 and 8 mg/l, respectively. When 4 mg/l tazobactam was added, the MICs of ceftriaxone for 83 of 94 strains of the Bacteroides fragilis group were reduced by a factor of 8 to 512; for eight strains, this reduction was two to fourfold. Only the MICs of ceftriaxone for three Bacteroides fragilis strains were not influenced.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8013494     DOI: 10.1007/bf01982195

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  12 in total

1.  Characterization of beta-lactamases from non-Bacteroides fragilis group Bacteroides spp. belonging to seven species and their role in beta-lactam resistance.

Authors:  P C Appelbaum; A Philippon; M R Jacobs; S K Spangler; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

Review 2.  Susceptibility testing of anaerobic bacteria: myth, magic, or method?

Authors:  H M Wexler
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

3.  Comparative in vitro activity of ceftriaxone against anaerobic bacteria.

Authors:  R D Rolfe; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

4.  Multilaboratory evaluation of the in vitro activity of 13 beta-lactam antibiotics against 1474 clinical isolates of aerobic and anaerobic bacteria.

Authors:  P R Murray; R N Jones; S D Allen; M E Erwin; P C Fuchs; E H Gerlach
Journal:  Diagn Microbiol Infect Dis       Date:  1993 Mar-Apr       Impact factor: 2.803

5.  Effect of beta-lactamase inhibitors on the activities of various beta-lactam agents against anaerobic bacteria.

Authors:  H M Wexler; E Molitoris; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

6.  Effect of clavulanic acid, sulbactam and tazobactam on three different beta-lactamases from Bacteroides uniformis, Clostridium butyricum and Fusobacterium nucleatum.

Authors:  M Hedberg; L Lindqvist; K Tunér; C E Nord
Journal:  J Antimicrob Chemother       Date:  1992-07       Impact factor: 5.790

7.  Cephalosporin-resistance in the Bacteroides fragilis group and the effect of clavulanic acid.

Authors:  J P Maskell; M Nasu; J D Williams
Journal:  J Antimicrob Chemother       Date:  1984-01       Impact factor: 5.790

Review 8.  Comparative susceptibility profile of piperacillin/tazobactam against anaerobic bacteria.

Authors:  P C Appelbaum
Journal:  J Antimicrob Chemother       Date:  1993-01       Impact factor: 5.790

9.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

10.  Effect of clavulanic Acid on anaerobic bacteria resistant to Beta-lactam antibiotics.

Authors:  J Wüst; T D Wilkins
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.